Insurance distribution stocks had their worst session in years on Thursday, 24 September, after the Insurance Regulatory and Development Authority of India (IRDAI) proposed sweeping caps on the commissions and management expenses that underpin how policies are sold in the country. Shares of PB Fintech, the parent of Policybazaar, fell 36% in a single day and slipped another 4% on Friday to a 52-week low of ₹1,115.10.
The trigger was a discussion paper titled “Recalibrating Economics of Insurance Distribution”, released by the regulator on 23 September. It invites comments until 25 October 2026 and lays out a phased reset of what insurers may spend on acquiring business, how much intermediaries can earn, and how banks and non-banking financial companies (NBFCs) may sell policies to borrowers.
What the regulator has proposed
At the heart of the paper is a tighter ceiling on expenses of management (EoM), the overall pool from which insurers pay commissions, salaries and marketing costs. For life insurers, the proposal is to bring EoM down to 15% of gross direct premium within two years and to 12.5% within five years. General insurers would move to 20% of domestic gross direct premium over five years, from 30% of gross written premium now. Business Standard reported that standalone health insurers would see their limit cut from 35% to 25%.
Within life insurance, commission caps would be linked to the premium-paying term of a policy. For policies sold by distribution entities, the cap would range from 5% for terms under five years to 20% for terms of ten years or more; agents would get slightly higher ceilings, from 6.25% to 25%. Renewal commission would be capped at 3% for distribution entities and 5% for agents. Single-premium savings products would carry just 1% and 2% respectively.
The sharpest cuts fall on products that are commonly sold alongside loans. According to Business Standard, commission on credit life cover would be capped at 2%, against about 28% now, while motor own-damage commission would drop to 5% from 16% and motor third-party would carry none. Reports differ on the proposed health caps — Business Standard cited 5%, while Business Today reported first-year caps of 15–20% — so the final text will need close reading on that point.
The regulator has also proposed a ban on bundling insurance with loans, a clawback of commission where mis-selling is established, an end to volume-linked incentives for bank and NBFC staff, and mandatory commission disclosure. Distributor categories would be simplified into three buckets.
Why IRDAI is acting now
The numbers in the paper explain the urgency. Broker commissions rose from 8.5% of premium in FY23 to 17% in FY25. In motor insurance, commissions grew 259% over those two years while premiums rose only 34%. In life insurance sourced through NBFCs, 42% of premium was paid out as commission in FY25. For a regulator focused on policyholder value and on curbing mis-selling, those figures show distribution costs growing far faster than the protection customers are actually buying.
How the market reacted
The selling on 24 September was broad but uneven. Along with PB Fintech’s 36% slide, Turtlemint fell 20%, Max Financial Services 9.8%, L&T Finance 9%, HDFC Life 6.2%, Bajaj Finance 5.9% and ICICI Prudential Life 4.1%, according to market data compiled by Marketcalls. Some general insurers moved the other way: ICICI Lombard gained 5.1% and Go Digit 2.2%, as investors bet that lower acquisition costs would help underwriters with strong direct channels.
The damage to NBFC stocks reflects how much fee income lenders now earn from cross-selling cover. Insurance distribution accounted for 26% of L&T Finance’s profit before tax in FY26 and 38.4% of Piramal Finance’s in FY25, Business Standard reported.
What analysts are saying
Brokerages broadly described the proposal as a structural reset rather than a tweak. Axis Securities called it a “material reset” that would hurt brokers the most. Motilal Oswal estimated that the commission on a typical health policy could fall from around ₹15,000 to ₹3,500–3,750, partly offset by a 15–20% recovery in volumes and 10–15% cost savings. Systematix said the changes were negative for most private life insurers, with SBI Life a likely exception. Deloitte India’s Debashish Banerjee flagged an immediate margin squeeze for banks and NBFCs that sell insurance, while Nomura pointed to the risk of weaker distributor motivation.
Some analysts quoted by Business Standard expect commissions in the highest-margin categories to shrink by 70–90%. PB Fintech is reportedly weighing whether to become an insurer itself to offset the hit, though the company has not announced any such move.
Why it matters for investors
The proposal reprices an entire value chain. Listed distributors and fintech aggregators face the most direct earnings risk, since commission is effectively their revenue. Lenders that have leaned on insurance cross-selling to support return ratios will need to replace that income or accept lower profitability. Life insurers with agency-heavy or bank-partner models will have to rework product design and payouts, while efficient general insurers could see margins improve.
For policyholders, lower commissions could in time mean better value on savings products and fewer policies pushed through with loans. The counter-argument, which the industry is likely to press during consultation, is that thinner payouts could slow insurance penetration in a country where coverage remains low.
What happens next
Stakeholders have until 25 October to submit comments. The changes are proposed to phase in over two to five years, and existing arrangements will not change overnight. Insurers, brokers and lenders are expected to push back hard on the steepness of the caps, especially for health and credit-linked products. Until the final regulations are notified, the sector is likely to trade on headlines from that consultation and on management commentary during the September-quarter earnings season.
